27/01/2026
https://zurl.co/FP46Z Severe community-acquired pneumonia has high short-term and one-year mortality and can lead to acute and long-term sequelae. Pathogen identification often remains negative, but multiplex PCR and urinary antigens can accelerate targeted therapy and support antibiotic stewardship. Corticosteroid trial results conflict, with benefit appearing linked to high initial CRP and harm suggested in influenza.